Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rag GTPases are a family of small GTP-binding proteins, including RagA, RagB, RagC, and RagD, that serve as critical nutrient sensors in eukaryotic cells [UniProt]. They function as obligate heterodimers, typically consisting of RagA or RagB paired with RagC or RagD, localized to the lysosomal membrane [PMID: 18497260]. In the presence of amino acids, the Rag complex adopts an active state (RagA/B-GTP and RagC/D-GDP) that recruits the mechanistic target of rapamycin complex 1 (mTORC1) to the lysosome, where it can be activated by Rheb [PMID: 18589070]. This recruitment is a fundamental step in coupling nutrient availability to cell growth, protein synthesis, and autophagy [PubMed]. Mutations in the Rag GTPase genes, particularly RRAGC, have been identified as drivers in follicular lymphoma, where they lead to constitutive mTORC1 activation independent of nutrient levels [PMID: 28114296]. While direct pharmacological inhibitors of Rag GTPases are currently in the preclinical stage, they represent a promising strategy for treating cancers and metabolic diseases characterized by aberrant mTORC1 signaling [Nature Reviews Drug Discovery]. Targeting the Rag-mTORC1 interaction may offer greater specificity and fewer side effects compared to traditional mTOR inhibitors like rapamycin [PMID: 25457612].
Inhibition of mTORC1 recruitment to the lysosomal surface by preventing the formation of the active Rag GTPase heterodimer complex [PMID: 18497260]. This can be achieved through competitive inhibition of GTP binding or stabilization of the inactive GDP-bound state of RagA/B [PMID: 25457612].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras-related GTP-binding protein (Rag GTPase) (Rag GTPase).